谷歌浏览器插件
订阅小程序
在清言上使用

Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.

The Journal of rheumatology(2022)

引用 5|浏览4
暂无评分
摘要
IRR of TNFi-induced PsO was not significantly different among ADA, IFX, and ETN. However, for patients with exposure to any of the TNFi evaluated, the IRR was significantly lower in those also exposed to a DMARD.
更多
查看译文
关键词
disease-modifying antirheumatic agents,juvenile idiopathic arthritis,psoriasis,tumor necrosis factor inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要